The Role of Sleeve Gastrectomy on Preventing Type 2 Diabetes Mellitus

Serdar Olt; Sabri Ã–zdaÅŸ; Mehmet Åžirik

doi:10.3889/oamjms.2017.074

Authors

Serdar Olt AdÄ±yaman University Medical Faculty, Department of General Surgery, AdÄ±yaman
Sabri Ã–zdaÅŸ AdÄ±yaman University Medical Faculty, Department of Internal Medicine, AdÄ±yaman
Mehmet Åžirik AdÄ±yaman University Medical Faculty, Department of Radiology, AdÄ±yaman

DOI:

https://doi.org/10.3889/oamjms.2017.074

Keywords:

Bariatric Surgery, Sleeve Gastrectomy, Type 2 Diabetes Mellitus, HbA1c, Blood Sugar Regulation

Abstract

AIM: To investigate the effect of bariatric surgery on HbA1c and serum cortisol levels in morbidly obese patients without type 2 diabetes mellitus.

MATERIALS AND METHODS: Twenty-nine patients who underwent sleeve gastrectomy and whose body mass index was> 40 were included in the present study. Patients' files were reviewed retrospectively. Those with diabetes mellitus and those with age <18 were excluded from the study. Pre-operative and 1-year post operative data were documented. The obtained data were analysed by SPSS statistical program.

RESULTS: The mean age of the patients was 27.4 Â± 8.4. 5 of the patients were male, and 24 were female. The mean body mass index of the patients was 44 Â± 2.3. 1 patient [3.4%] had hypertension. Four patients [13.7%] had gastroesophageal reflux disease. The number of smokers was 7 [24.1%], and the number of alcohol users was 3 [10.3%]. There was a statistically significant decrease in HbA1c, body mass index values after operation [p value <0.01], but cortisol was not different [p value = 0.72].

CONCLUSION: In this present study we found that bariatric surgery caused a significant decrease in HbA1c levels in non-diabetic patients, suggesting that bariatric surgery may prevent Type 2 Diabetes Mellitus in obese patients.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Hafez D, Fedewa A, Moran M, O'Brien M, Ackermann R, Kullgren JT. Workplace Interventions to Prevent Type 2 Diabetes Mellitus: a Narrative Review. Curr Diab Rep. 2017;17(2):9. https://doi.org/10.1007/s11892-017-0840-0 PMid:28150162

Sugiyama Y, Shimura Y, Ikeda H. Pathogenesis of hyperglycemia in genetically obese-hyperglycemic rats, Wistar fatty: presence of hepatic insulin resistance. Endocrinol Jpn. 1989;36(1):65-73. https://doi.org/10.1507/endocrj1954.36.65 PMid:2543549

Oakes ND, Cooney GJ, Camilleri S, Chisholm DJ, Kraegen EW. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes. 1997;46(11):1768-74. https://doi.org/10.2337/diab.46.11.1768 PMid:9356024

Busetto L. Timing of bariatric surgery in people with obesity and diabetes. Annals of Translational Medicine. 2015;3(7):94. PMid:26015936 PMCid:PMC4430740

Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, Aminian A, Pothier CE, Kim ES, Nissen SE, Kashyap SR. STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. N Engl J Med. 2014;370(21):2002-13. https://doi.org/10.1056/NEJMoa1401329 PMid:24679060 PMCid:PMC5451259

Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, Navaneethan SD, Singh RP, Pothier CE, Nissen SE, Kashyap SR. STAMPEDE Investigators.. Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med. 2017;376(7):641-651. https://doi.org/10.1056/NEJMoa1600869 PMid:28199805

Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, Aminian A, Pothier CE, Kim ES, Nissen SE, Kashyap SR; STAMPEDE Investigators, Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. N Engl J Med. 2014;370(21):2002-13. https://doi.org/10.1056/NEJMoa1401329 PMid:24679060 PMCid:PMC5451259

Blackstone R, Bunt JC, CortÃ©s MC, Sugerman HJ. Type 2 diabetes after gastric bypass: remission in five models using HbA1c, fasting blood glucose, and medication status. Surg Obes Relat Dis. 2012;8(5):548-55. https://doi.org/10.1016/j.soard.2012.05.005 PMid:22721581

Psaltopoulou T, Hatzis G, Papageorgiou N, Androulakis E, Briasoulis A, Tousoulis D. Socioeconomic status and risk factors for cardiovascular disease: impact of dietary mediators. Hellenic J Cardiol. 2017. pii: S1109-9666(17)30040-4.

Park YM, White AJ, Nichols HB, O'Brien KM, Weinberg CR, Sandler DP. The association between metabolic health, obesity phenotype and the risk of breast cancer. Int J Cancer. 2017. https://doi.org/10.1002/ijc.30684

Zhang G. Morbid obesity: a well-established burden on knee prosthesis after total knee arthroplasty. Annals of Translational Medicine. 2015;3(19):293. PMid:26697453 PMCid:PMC4671871

White AJ, Nichols HB, Bradshaw PT, Sandler DP. Overall and central adiposity and breast cancer risk in the Sister Study. Cancer. 2015;121(20):3700-8. https://doi.org/10.1002/cncr.29552 PMid:26193782 PMCid:PMC4592412

Chan M. Obesity and Diabetes: The Slow-Motion Disaster. Milbank Q. 2017;95(1):11-14. https://doi.org/10.1111/1468-0009.12238 PMid:28266071

GarcÃa Casilimas GA, Martin DA, MartÃnez MA, MerchÃ¡n CR, Mayorga CA, BarragÃ¡n AF. [Pathophysiology of hypertension secondary to obesity]. Arch Cardiol Mex. 2017. pii: S1405-9940(17)30010-1.

Deshpande BR, Katz JN, Solomon DH, Yelin EH, Hunter DJ, Messier SP, Suter LG, Losina E. Number of Persons With Symptomatic Knee Osteoarthritis in the US: Impact of Race and Ethnicity, Age, Sex, and Obesity. Arthritis Care Res [Hoboken]. 2016;68(12):1743-1750. https://doi.org/10.1002/acr.22897 PMid:27014966

Lee WJ, Aung L. Metabolic Surgery for Type 2 Diabetes Mellitus: Experience from Asia. Diabetes Metab J. 2016;40(6):433-443. https://doi.org/10.4093/dmj.2016.40.6.433 PMid:27990787 PMCid:PMC5167707

Campos J, Ramos A, Szego T, Zilberstein B, Feitosa H, Cohen R. The role of metabolic surgery for patients with obesity grade i and type 2 diabetes not controlled clinically. Arq Bras Cir Dig. 2016;29 (Suppl 1):102-106. https://doi.org/10.1590/0102-6720201600S10025 PMid:27683788 PMCid:PMC5064276

Health Quality Ontario. Bariatric surgery for people with diabetes and morbid obesity: an evidence-based analysis. Ont Health Technol Assess Ser. 2009;9(22):1-23.

FernÃ¡ndez-Soto ML, MartÃn-Leyva A, GonzÃ¡lez-JimÃ©nez A, GarcÃa-Rubio J, CÃ³zar-IbÃ¡-ez A, Zamora-Camacho FJ, Leyva-MartÃnez MS, JimÃ©nez-RÃos JA, Escobar-JimÃ©nez F. Remission of type 2 diabetes mellitus after bariatric surgery - comparison between procedures. Endokrynol Pol. 2017;68(1):18-25. https://doi.org/10.5603/EP.2017.0004 PMid:28255977

Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, Nanni G, Pomp A, Castagneto M, Ghirlanda G, Rubino F. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012 Apr 26;366(17):1577-85. https://doi.org/10.1056/NEJMoa1200111 PMid:22449317